Literature DB >> 29228306

25S rDNA genotype and antifungal susceptibility of clinical Candida albicans in Ouagadougou (Burkina Faso).

Adama Zida1,2,3, Soulama Issiaka4, Bamba Sanata3, Serme S Samuel4,5, Sangare Ibrahim3,6, Sawadogo Marcel1,2, Guiguemde Thierry2,7, Traore Lady Kady2, Guiguemde T Robert2,3.   

Abstract

The present investigation aimed to assess the prevalence of genotypes of C. albicans in Ouagadougou and to analyze the relationship between the genetic diversity and antifungal susceptibility. Ninety-six clinical strains are included. They were diagnosed as C. albicans using germ tube test, chlamydospore formation, and Api-Candida test. Genotyping was performed using PCR targeting 25S rDNA. Antifungal susceptibilities were tested based on the disk diffusion method. The genotypes A (85.4%) was predominant followed by genotypes B (10.4%) and C (4.2%). The highest resistance rate with genotype A was obtained with fluconazole (74.4%). A resistance to amphotericin B was observed with genotypes A (29.3%) and B (30%).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29228306     DOI: 10.1093/mmy/myx127

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  1 in total

1.  Genotype Analysis of Clinical Candida albicans Isolates Using PCRs Targeting 25S rDNA and ALT Repeat Sequences of the RPS and Antifungal Susceptibility in Ouagadougou (Burkina Faso).

Authors:  Patindoilba Marcel Sawadogo; Adama Zida; Issiaka Soulama; S Samuel Sermé; Kiswendsida Thierry Guiguemdé; Richard Junior; Ibrahim Sangaré; Sanata Bamba; Rasmata Ouédraogo-Traoré; Tinga Robert Guiguemdé
Journal:  Infect Drug Resist       Date:  2019-12-16       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.